The Arginine-creatine pathway is disturbed in children and adolescents with renal transplants

Pediatric Research

Volumn 64, Issue 2, 2008, Pages 218-222

  Andrade, Fernando ^a   Rodríguez Soriano, Juan ^a   Prieto, Josi Angel ^a   Elorz, Javier ^a   Aguirre, Mireia ^b   Ariceta, Gema ^b   Martin, Sergio ^a   Sanjurjo, Pablo ^a   Aldámiz Echevarría, Luis ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CITRULLINE; CREATINE; CREATININE; CYCLOSPORIN A; GLYCINE; GUANIDINOACETIC ACID; HOMOCYSTEINE; METHIONINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORNITHINE; PREDNISONE; RAPAMYCIN; TACROLIMUS; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AMINO ACID METABOLISM; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; METHYLATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; URINARY EXCRETION; URINE LEVEL; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; DRUG EFFECT; KIDNEY; METABOLISM; RISK FACTOR; URINE;

ADOLESCENT; ARGININE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; CREATINE; CREATININE; FEMALE; GLYCINE; HOMOCYSTEINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; METHYLATION; RISK FACTORS;

EID: 52649143219     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318176180e     Document Type: Article

References (45)

1. Parekh RS, Carroll CE, Wolfe RA, Port FK 2002 Cardiovascular mortality in children and young adults with end-stage disease. J Pediatr 141:191-197
2. Silverstein DM, Palmer J, Polinsky MS, Brass C, Conley SB, Baluarte HJ 2000 Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients. Pediatr Nephrol 14:105-110
3. Hjelmesaeth J, Midtvedt K, Jenssen T, Hartmann A 2001 Insulin resistance after renal transplantation. Diabetes Care 24:2121-2126
4. Greenspan LC, Gitelman SE, Leung MA, Glidden DV, Mathias RS 2002 Increased incidence of post-transplant diabetes mellitus in children: a case-control analysis. Pediatr Nephrol 17:1-5
5. Aldamiz-Echevarria L, Sanjurjo P, Vallo A, Aquino L, Perez-Nanclares G, Gimeno P, Rueda M, Ruiz JI, Urreizti R, Rodriguez-Soriano J 2002 Hyperhomocysteinemia in children with renal transplants. Pediatr Nephrol 17:718-723
6. Aldamiz-Echevarria L, Sanjurjo P, Vallo A, Aguirre M, Perez-Nanclares G, Gimeno P, Rueda M, Ruiz JI, Rodriguez-Soriano J 2003 Genetic and metabolic determinants of increased plasma plasminogen activator inhibitor-1 activity in children with renal transplants. Pediatr Nephrol 18:749 -755
7. Mendes Ribeiro AC, Brunini TM, Ellory JC, Mann GE 2001 Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure. Cardiovasc Res 49:697-712
8. Fleck C, Schweitzer F, Karge E, Busch M, Stein G 2003 Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clin Chim Acta 336:1-12
9. Busch M, Fleck C, Wolf G, Stein G 2006 Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potencial risk factors for cardiovascular and renal outcome in chronic kidney disease-possible candidates for paradoxical epidemiology? Amino Acids 30:225-232
10. Böger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP 1998 Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction. Circulation 98:1842-1847.
11. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A 1976 A simple estimate of glomerular filtration rate on children derived from body weight and plasma creatinine. Pediatrics 58:259 -263
12. Arias A, Garcia-Villoria J, Ribes A 2004 Guanidinoacetate and creatine/creatinine levels in controls and patients with urea cycle defects. Mol Genet Metab 82:220 -223
13. Behram RE, Kliegman RM, Jenson HB 2004 Nelson Textbook of Pediatrics. 17th ed. Madrid, Spain: Elsevier Science Ed, pp 2404
14. Vilaseca MA, Moyano D, Ferrer I, Artuch R 1997 Total homocysteine in pediatric patients. Clin Chem 43:690 -692
15. Shih VE 2003 Amino Acid Analysis. In: Blau N, Duran M, Blaskovics ME, Gibson KM (eds) Physician's Guide to the Laboratory Diagnosis of Metabolic Disease. Heidelberg, Germany: Springer-Verlag, pp 11-26
16. Braissant O, Henry H, Villard AM, Speer O, Wallimann T, Bachmann C 2005 Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC Dev Biol 5:9
17. Morris SM 2004 Enzymes of arginine metabolism. J Nutr 134:2743S-2747S
18. Scibior D, Czeczot H 2004 [Arginine-metabolism and functions in the human organism]. Postepy Hig Med Dosw (Online) 58:321-332
19. Brosnan ME, Brosnan JT 2004 Arginine metabolism: enzymology, nutrition, and clinical significance. J Nutr 134:2791S-2795S
20. Yin M, Zhong Z, Connor HD, Bunzendahl H, Finn WF, Rusyn I, Li X, Raleigh JA, Mason RP, Thurman RG 2002 Protective effect of glycine on renal injury induced by ischemia-reperfusion in vivo. Am J Physiol Renal Physiol 282:F417-F423
21. Kuroda M 1993 Study on impaired metabolism of guanidinoacetic acid in chronic renal failure rabbits with special reference to impaired conversion of arginine to guanidinoacetic acid. Nephron 65:605-611
22. Al Banchaabouchi M, Marescau B, Van Marck E, D'hooge R, De Deyn PP 2001 Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice. Metabolism 50:1418 -1425
23. Tofuku Y, Muramoto H, Kuroda M, Takeda R 1985 Impaired metabolism of guanidinoacetic acid in uremia. Nephron 41:174-178
24. Marescau B, Nagels G, Possemiers I, De Broe ME, Because I, Billiouw JM, Lornoy W, De Deyn PP 1997 Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency. Metabolism 46:1024-1031
25. Kiyatake I, Nakamura T, Koide H 2004 Urinary guanidinoacetic acid excretion as an indicator of gentamicin nephotoxicity in rats. Ren Fail 26:339 -344
26. McLin VA, Girardin E, Lecoultre C, Mentha G, Belli DC 2005 Glomerular and tubular function following orthotopic liver transplantation in children. Pediatr Transplant 9:512-519
27. Morris ST, McMurray JJ, Rodger RS, Farmer R, Jardine AG 2000 Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 57:1100 -1106
28. Takeda Y, Miyamori I, Furukawa K, Inaba S, Mabuchi H 1999 Mechanisms of FK 506-Induced hypertension in the rat. Hypertension 33:130 -136
29. Handy DE, Scolaro J, Chen J, Huang P, Loscalzo J 2004 L-arginine increases plasma homocysteine in apoE-/-/iNOS-/- double knockout mice. Cell Mol Biol 50:903-909
30. Finkelstein JD 1998 The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 157:S40 -S44
31. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ 2000 Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomo- cysteine and lymphocyte DNA hypomethylation. J Biol Chem 275:29318 -29323
32. Perna AF, Ingrosso D, Galletti P, Zappia V, De Santo NG 1996 Membrane protein damage and methylation reactions in chronic renal failure. Kidney Int 50:358 -366
33. Wollesen F, Brattström L, Refsum H, Ueland PM, Berglund L, Berne C 1999 Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 55:1028 -1035
34. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J 2001 Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73:613-621
35. Koehler KM, Romero LJ, Stauber PM, Pareo-Tubbeh SL, Liang HC 1996 Vitamin supplementation and other variables affecting serum homocysteine and methylma- lonic acid concentrations in elderly men and women. J Am Coll Nutr 15:364-376
36. Ganji V, Kafai MR 2003 Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 77:826-833
37. Castillo L, Beaumier L, Ajami AM, Young VR 1996 Whole body nitric oxide synthesis in healthy men determined from [15N]arginine-to-[15N]citrulline labelling. Proc Natl Acad Sci USA 93:11460 -11465
38. Vos IH, Rabelink TJ, Dorland B, Loos R, Van Middelaar B, Grone HJ, Joles JA 2001 L-arginine supplementation improves function and reduces inflammation in renal allografts. J Am Soc Nephrol 12:361-367
39. Ponticelli C, Campise MR 2005 Neurological complications in kidney transplant recipients. J Nephrol 18:521-528
40. Braissant O, Henry H, Loup M, Eilers B, Bachmann C 2001 Endogenous synthesis and transport of creatine in the rat: an in situ hybridization study. Brain Res Mol Brain Res 86:193-201
41. Schulze A 2003 Carnitine deficiency syndromes. Mol Cell Biochem 244:143-150
42. Battini R, Alessandrï MG, Leuzzi V, Moro F, Tosetti M, Bianchi MC, Cioni G 2006 Arginine:glycine amidinotransferase (AGAT) deficiency in a newborn: early treatment can prevent phenotypic expression of the disease. J Pediatr 148:828 -830
43. Laakkonen H, Lonnqvist T, Uusimaa J, Qvist E, Valanne L, Nuutinen M, Ala- Houhala M, Majamaa K, Jalanko H, Holmberg C 2006 Muscular dystonia and athetosis in six patients with congenital nephrotic syndrome of the Finnish type (NPHS1). Pediatr Nephrol 21:182-189
44. Aldamiz-Echevarría L, Vallo A, Sanjurjo P, Gonzalez-Lamuño P, Elorz J, Prieto JA, Andrade F, Rodriguez-Soriano J 2007 Essential fatty acid deficiency profile in patients with nephrotic-range proteinuria. Pediatr Nephrol 22:533-540
45. Leuzzi V 2002 Inborn errors of creatine metabolism and epilepsy: clinical features, diagnosis, and treatment. J Child Neurol 3:3S89 -3S97